eng eng eng

Programme

Download as PDF
Thursday, 21 May 2026 Friday, 22 May 2026 Saturday, 23 May 2026
Conference room
12:00 – 14:30
Beginning of the conference
Introductory lecture: Neurocutaneous diseases — challenges and successes

Session I. Tuberous Sclerosis Complex (TSC): Drug-resistant epilepsy and its consequences
Epilepsy and its complications in TSC
Treatment of drug-resistant epilepsy in TSC — new antiseizure drugs
Treatment of agitation and behavioral disorders in TSC — use of cannabinoids
Ketogenic diet in drug-resistant epilepsy
Vagus nerve stimulator and surgical treatment of epilepsy in TSC
150 min
14:30 – 15:00
Coffee break 30 min
15:00 – 16:00
Corporate session I
60 min
16:15 – 19:05
Session II. Tuberous sclerosis complex: Organ changes
Subependymal giant cell astrocytoma (SEGA) brain tumors and their treatment — neurosurgical and mTOR inhibitors (everolimus and rapamycin)
Skin symptoms in tuberous sclerosis and their treatment
mTOR inhibitors in the treatment of skin lesions
Nephrological complications of tuberous sclerosis complex — treatment of angiomyolipoma tumors
Treatment of ophthalmological symptoms in TSC
Treatment of manifestations of cardiac tumors — surgery and mTOR inhibitors
170 min
20:00 – 22:00
Dinner 120 min
Conference room
08:30 – 10:30
Session III.  Neurofibromatosis Type 1 (NF1)
Evolution of NF1 diagnostic criteria
Neurological symptoms of NF1 and their treatment
Treatment of skin lesions and plexiform neurofibromas in NF1
Treatment of neurofibromas with selumetinib
120 min
10:30 – 11:00
Coffee break 30 min
11:00 – 12:30
Session IV. NF1
Treatment of optic nerve gliomas in NF1
Arterial hypertension and treatment in NF1
NF1 genetics — other forms of neurofibromatosis
Legius syndrome
90 min
12:30 – 13:30
Lunch and poster session 60 min
13:30 – 14:30
Pharma session II
60 min
14:45 – 16:45
Session V. Sturge-Weber syndrome
Sturge-Weber syndrome: epilepsy, paresis, brain bleeding — treatment
Treatment of vascular mole on the face in patients with Sturge-Weber syndrome
ADHD and Conduct Disorders
120 min
16:45 – 17:15
Coffee break 30 min
17:15 – 19:00
Session VI. Other rare skin and nerve diseases
Jadassohn syndrome: treatment of neurological and skin lesions — laser therapy
Hippel-Lindau disease — kidney and brain tumors and retinal detachment
Sleep disorders in patients with cutaneous and nervous diseases
105 min
20:00 – 22:00
Gala dinner 120 min
Conference room
08:30 – 10:00
Session VII. New techniques in the diagnosis and treatment of neurocutanous disorders
Neurocutanous disorders in the era of large-scale genetic testing
New techniques for the treatment of ocular lesions in neurocutaneous diseases
New dermatological techniques in the treatment of skin lesions in neurocutaneous diseases
Radiological methods in the diagnosis of organ changes in cutaneous and nervous diseases
90 min
10:00 – 10:30
Coffee break 30 min
10:30 – 11:30
Session VIII. Highlights, posters winners, and Conference summary and conclusion
60 min
Download program as PDF
Copyrights © 2025 Via Medica

Informacje o plikach cookie

Niezbędne pliki cookie

Zawsze aktywne

Te pliki cookie są niezbędne do prawidłowego wyświetlania i działania strony internetowej. Zablokowanie ich może spowodować nieprawidłowe działanie strony.

Analityczne pliki cookie

W ramach naszej strony internetowej korzystamy z narzędzi analitycznych, takich jak Google Analytics, które umożliwiają nam weryfikację ruchu na stronie internetowej. Narzędzia te mogą wymagać użycia plików cookie.

Społecznościowe pliki cookie

Są to pliki cookie powiązane z portalami społecznościowymi, z których korzystamy. Zaakceptowanie ich pozwoli na powiązanie Twojej wizyty na stronie z naszymi profilami w mediach społecznościowych.

Marketingowe pliki cookie

Są to pliki cookie odpowiedzialne za prowadzenie działań reklamowych i marketingowych - zgoda na ich wykorzystanie pozwoli nam kierować do Ciebie reklamy, bazujące na podstawie Twoich wcześniejszych aktywności w ramach naszej stronie internetowej.

The conferences website uses cookies. These are small text files sent by the www server and stored by the computer browser software. When the browser reconnects to the site, the site recognizes the type of device the user connects from.
Parameters allow to read the information contained in it, only to the server that created them. Cookies therefore facilitate the use of previously visited websites.